Anaplastic thyroid cancer (ATC) is one of the most aggressive solid organ cancers with high mortality. Even after so much progress in chemotherapy, radiotherapy, and surgical techniques, we lose almost all patients within 2 years of diagnosis. The very low threshold for suspecting ATC and Prompt diagnosis are crucial factors in the management of ATC.
Liu TR, Xiao ZW, Xu HN, et al. Treatment and prognosis of anaplastic thyroid carcinoma: A clinical study of 50 Cases. PLoS One 2016; 11(10):e0164840. DOI: 10.1371/journal.pone.0164840.
Meti-Raghava MH, Kumar C. Anaplastic thyroid carcinoma: Spot diagnosis. Indian J Endoc Surg Res 2021;16(2):89–90. DOI: 10.5005/jp-journals-10088-11168.
Brennan M, French J. Thyroid lumps and bumps. Aust Fam Physician 2007;36(7):531–536. PMID: 17619669.
Broome JT, Gauger PG, Miller BS, et al. Anaplastic thyroid cancer manifesting as new-onset Horner syndrome. Endocr Pract 2009; 15(6):563–566. DOI: 10.4158/EP09106.CRR.
Takashima S, Morimoto S, Ikezoe J, et al. CT evaluation of anaplastic thyroid carcinoma. AJR Am J Roentgenol 1990;154(5):1079–1085. DOI: 10.2214/ajr.154.5.2108546.
Ng TSC, Gunda V, Li R, et al. Detecting immune response to therapies targeting PDL1 and BRAF by using ferumoxytol MRI and macrin in anaplastic thyroid Cancer. Radiology 2021;298(1):123–132. DOI: 10.1148/radiol.2020201791.
